Atrial Fibrillation with Rapid Ventricular Response in Subdural Hemorrhage

Pathophysiology and Risk Factors

Progressive atrial fibrosis develops with age, replacing approximately 0.5-1.0% of cardiomyocytes per year with fibrous tissue, creating the substrate for sustained AF, according to the American College of Cardiology 1
Increased myocardial stiffness and left atrial dilation occur as consequences of aging-related structural remodeling, making elderly patients more susceptible to AF when exposed to acute triggers like subdural hemorrhage, as stated by the American Heart Association 1
Hypertension with left ventricular hypertrophy dramatically increases susceptibility to neurogenic AF, as reported by the American College of Cardiology 1
Coronary artery disease promotes AF through atrial ischemia and structural remodeling, which becomes acutely exacerbated during the stress of subdural hemorrhage, according to the European Society of Cardiology 1
Heart failure both promotes AF and is worsened by AF, with the acute hemodynamic stress of subdural hemorrhage potentially triggering decompensation, as stated by the Heart Failure Society of America 1

Standard pharmacologic rate control agents (beta blockers, calcium channel blockers) must be used with extreme caution in patients with subdural hemorrhage due to concerns about cerebral perfusion, as recommended by the European Society of Cardiology 2
Bradycardia and heart block may occur as unwanted effects, particularly dangerous in elderly patients with acute brain injury, according to the American Heart Association 2
Intravenous administration may be necessary when rapid control is required, but hemodynamic monitoring is essential, as stated by the European Society of Cardiology 2
Active intracranial bleeding precludes warfarin or direct oral anticoagulants regardless of stroke risk stratification scores, as recommended by the American Heart Association 3, 4
Even after subdural hemorrhage resolution, the decision to restart anticoagulation requires careful individualized assessment of bleeding versus thrombotic risk, according to the American College of Cardiology 4

AFib RVR reduces cardiac output by 15-20%, which can critically compromise cerebral perfusion in patients with already elevated intracranial pressure, as reported by the American Heart Association 5